Flavored waterpipe tobacco preferences, perceptions, and use in pregnant women: A latent factor mapping approach.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
03 2022
Historique:
received: 21 06 2021
revised: 17 11 2021
accepted: 20 11 2021
pubmed: 6 12 2021
medline: 2 2 2022
entrez: 5 12 2021
Statut: ppublish

Résumé

Waterpipe tobacco (WPT) use is increasingly common in young adults including pregnant and reproductive-age women. Sweet flavors contribute to the appeal of WPT and are a promising regulatory target. The present study utilized correspondence analysis of contingency tables, a latent factor mapping technique, to investigate preferences and perceptions of WPT flavors in a sample of racially/ethnically diverse, low-income pregnant women. One hundred pregnant women (mean age = 26 years, 65% racial/ethnic minorities) completed a detailed interview regarding their use, preferences, and perceptions of WPT flavors. Eighty-three percent of participants reported lifetime WPT use; 11% reported prenatal WPT use. Pregnant women reported greatest use of and stronger preferences for sweet (fruit, candy, alcohol) and menthol/mint flavors, and weaker preferences for tobacco flavored WPT. Latent factor mapping revealed clustering of preferred sweet (fruit, candy, alcohol) and menthol/mint flavors versus tobacco flavors, with pungent flavors (coffee, chocolate, spice) clustering between sweet and tobacco flavors. Preferences for sweet and menthol/mint flavors distinguished pregnant women who reported lifetime WPT versus no lifetime WPT use, and prenatal WPT use versus no prenatal WPT use. Harm perceptions did not vary by flavor. Regulations to restrict the availability of WPT flavors may reduce the appeal and use of WPT, especially among pregnant women.

Identifiants

pubmed: 34864479
pii: S0306-4603(21)00379-8
doi: 10.1016/j.addbeh.2021.107194
pmc: PMC8926392
mid: NIHMS1781933
pii:
doi:

Substances chimiques

Flavoring Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

107194

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA036999
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA042484
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA045492
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL076134
Pays : United States

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Références

Addiction. 2021 Apr;116(4):936-948
pubmed: 32896050
Prev Med. 2017 Nov;104:50-56
pubmed: 28789981
Tob Use Insights. 2016 Jul 05;9:13-28
pubmed: 27398028
Nat Rev Cancer. 2003 Oct;3(10):733-44
pubmed: 14570033
Curr Addict Rep. 2019 Jun;6(2):98-113
pubmed: 31453046
Prev Med Rep. 2019 Mar 22;14:100854
pubmed: 30976489
Addict Behav. 2019 Dec;99:106077
pubmed: 31437770
Chem Senses. 2017 May 1;42(4):279-286
pubmed: 28334158
Tob Control. 2015 Mar;24 Suppl 1:i3-i12
pubmed: 25298368
PLoS One. 2018 Feb 9;13(2):e0192191
pubmed: 29425207
Chemosens Percept. 2010 Mar;3(1):51-56
pubmed: 20352054
Nicotine Tob Res. 2015 Jul;17(7):810-8
pubmed: 25385873
J Food Sci. 2010 Mar;75(2):S141-7
pubmed: 20492260
Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1055-66
pubmed: 24836469
Fed Regist. 2016 May 10;81(90):28973-9106
pubmed: 27192730
Am J Prev Med. 2015 Jun;48(6):742-6
pubmed: 25890683
Tob Control. 2020 Feb;29(Suppl 2):s62-s71
pubmed: 31320397
Psychol Addict Behav. 2014 Mar;28(1):154-62
pubmed: 23276315
Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):765-72
pubmed: 23462922
Int J Environ Res Public Health. 2017 Mar 23;14(4):
pubmed: 28333107
Tob Control. 2015 Mar;24 Suppl 1:i13-i21
pubmed: 25618895
Am J Public Health. 2013 Nov;103(11):e21-3
pubmed: 24028247
Addict Behav. 2019 Apr;91:21-29
pubmed: 30446262
Nicotine Tob Res. 2011 Feb;13(2):78-87
pubmed: 21127030
Int J Epidemiol. 2017 Feb 1;46(1):32-43
pubmed: 27075769
Bull Menninger Clin. 2014 Summer;78(3):243-52
pubmed: 25247743
Am J Prev Med. 2009 Dec;37(6):518-23
pubmed: 19944918
Tob Control. 2015 Mar;24 Suppl 1:i31-i43
pubmed: 25661414
Tob Control. 2020 Feb;29(Suppl 2):s72-s79
pubmed: 31767788
Asian Pac J Cancer Prev. ;18(2):495-502
pubmed: 28345836
Am J Health Behav. 2018 May 1;42(3):37-46
pubmed: 29663979
Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2793-809
pubmed: 25416714

Auteurs

Laura R Stroud (LR)

Center for Behavioral and Preventive Medicine, The Miriam Hospital, Coro West, Suite 309, 164 Summit Avenue, Providence, RI 02906, USA; Department of Psychiatry and Human Behavior, Alpert Medical School, Brown University, Box G-BH, Providence, RI 02912, USA. Electronic address: Laura_Stroud@brown.edu.

George D Papandonatos (GD)

Department of Biostatistics, School of Public Health, Brown University, 121 South Main Street, Room 703, Providence, RI 02903, USA. Electronic address: gdp@stat.brown.edu.

Eva Sharma (E)

Behavioral Health and Health Policy Practice, Westat, Rockville, MD, USA. Electronic address: EvaSharma@westat.com.

Nancy C Jao (NC)

Center for Behavioral and Preventive Medicine, The Miriam Hospital, Coro West, Suite 309, 164 Summit Avenue, Providence, RI 02906, USA; Department of Psychiatry and Human Behavior, Alpert Medical School, Brown University, Box G-BH, Providence, RI 02912, USA. Electronic address: Nancy_Jao@brown.edu.

Samantha Goldman (S)

Department of Psychology, Adelphi University, Hy Weinberg Center, Room 308, Garden City, NY 11530, USA. Electronic address: Samanthagoldman@mail.adelphi.edu.

Chrystal Vergara-Lopez (C)

Center for Behavioral and Preventive Medicine, The Miriam Hospital, Coro West, Suite 309, 164 Summit Avenue, Providence, RI 02906, USA; Department of Psychiatry and Human Behavior, Alpert Medical School, Brown University, Box G-BH, Providence, RI 02912, USA. Electronic address: Chrystal_Vergara-Lopez@brown.edu.

Lori A J Scott-Sheldon (LAJ)

Center for Behavioral and Preventive Medicine, The Miriam Hospital, Coro West, Suite 309, 164 Summit Avenue, Providence, RI 02906, USA; Department of Psychiatry and Human Behavior, Alpert Medical School, Brown University, Box G-BH, Providence, RI 02912, USA. Electronic address: Lori_Scott-Sheldon@brown.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH